脳室ドレナージ市場規模、成長と動向分析レポート 2026-2033年

世界の脳室外ドレナージ市場規模は、2025年に16億1,000万米ドルと推定され、2033年には32億6,000万米ドルに達すると予測されています。2026年から2033年にかけての年平均成長率（CAGR）は9.29%です。世界的に外傷性脳損傷、脳卒中、水頭症、頭蓋内出血の発生率が増加していることが、市場成長の主な要因となっています。

主要市場動向と洞察

• 北米は、2025年に54.47%という最大の収益シェアを獲得し、脳室外ドレナージ市場を牽引しました。
• 米国は、2025年に最大の収益シェアを獲得し、北米市場をリードしました。
• 用途別では、外傷性脳損傷分野が2025年に最大の収益シェアを獲得し、市場をリードしました。
• 患者タイプ別では、成人分野が2025年に最大の収益シェアを獲得し、市場をリードしました。
• 最終用途別では、病院分野が2025年に最大の収益シェアを獲得し、市場をリードしました。

集中治療現場における効果的な頭蓋内圧モニタリングと脳脊髄液管理への需要の高まりが、機器導入の拡大を牽引しています。感染耐性カテーテル技術と統合型モニタリングシステムの進歩は、脳室外ドレナージ（EVD）業界の成長をさらに後押ししています。加えて、新興国における神経集中治療インフラの拡充と医療投資の増加が、世界市場の拡大を加速させています。

神経疾患の罹患率の上昇は、脳室外ドレナージ市場の成長を牽引する大きな要因です。外傷性脳損傷、脳卒中、脳内出血、水頭症、脳腫瘍などの症例増加に伴い、効果的な頭蓋内圧管理と脳脊髄液ドレナージの必要性が著しく高まっています。高齢化、高血圧などの生活習慣病リスク因子、神経救急疾患後の生存率向上も、患者数の増加に寄与しています。その結果、神経集中治療および救急医療現場における高度な脳室外ドレナージ（EVD）システムの需要は、世界的に拡大し続けています。

External Ventricular Drain Market Summary

The global external ventricular drain market size was estimated at USD 1.61 billion in 2025 and is projected to reach USD 3.26 billion by 2033, growing at a CAGR of 9.29% from 2026 to 2033. The rising incidence of traumatic brain injuries, stroke, hydrocephalus, and intracranial hemorrhage worldwide primarily drives the market growth.

The growing demand for effective intracranial pressure monitoring and cerebrospinal fluid management in critical care settings is driving increased device adoption. Advancements in infection-resistant catheter technologies and integrated monitoring systems are further supporting the growth of the external ventricular drain industry. In addition, expanding neurocritical care infrastructure and growing healthcare investments across emerging economies are accelerating global market expansion.

The rising prevalence of neurological disorders is a major driver of growth in the external ventricular drain market. Increasing cases of conditions such as traumatic brain injury, stroke, intracerebral hemorrhage, hydrocephalus, and brain tumors have significantly elevated the need for effective intracranial pressure management and cerebrospinal fluid drainage. Aging populations, lifestyle-related risk factors like hypertension, and higher survival rates following neurological emergencies are further contributing to the growing patient pool. As a result, the demand for advanced External Ventricular Drain (EVD) systems in neurocritical care and emergency settings continues to expand globally.

The growing incidence of road accidents and head trauma is a significant driver for the external ventricular drain market growth. Traumatic brain injuries resulting from motor vehicle collisions, falls, and sports-related accidents often lead to elevated intracranial pressure and intracranial bleeding, requiring immediate cerebrospinal fluid drainage. The increasing number of emergency admissions to trauma centers and intensive care units has amplified the demand for EVD systems as a critical life-saving intervention. Consequently, the rising global burden of head injuries continues to support market growth.

Thus, the increasing burden of neurological disorders and rising cases of head trauma are driving higher demand for external ventricular drain systems. The growing need for rapid intracranial pressure management in emergencies and neurocritical care settings continues to support steady market expansion.

Market Concentration & Characteristics

The external ventricular drain market is experiencing meaningful innovation focused on safety, functionality, and clinical efficiency. Manufacturers are developing antimicrobial and antibiotic-impregnated catheters, closed-system drainage designs, and integrated digital intracranial pressure (ICP) monitoring to reduce infection risk and improve patient outcomes. Advances in biocompatible materials and smart sensor technologies are enhancing device reliability and usability. Overall, innovation centers on minimizing complications and supporting precision neurocritical care across diverse clinical settings. For instance, in March 2025, Anuncia Medical, Inc. received FDA Breakthrough Device Designation for its ReFlow EVD, an innovative solution designed to improve the performance of external ventricular drains in managing elevated intracranial pressure. This milestone builds on the success of its ReFlow portfolio and strengthens the company’s position in advancing acute and long-term CSF management within neurocritical care.

“This regulatory milestone highlights the broader impact of our ReFlow innovation beyond hydrocephalus management,” said Elsa Chi Abruzzo, CEO and President of Anuncia Medical. “We continue to hear from neurosurgeons, nurses, patients, and families that ReFlow’s simple, seconds-long manual flush helps prevent blockages-improving outcomes and providing peace of mind. Expanding our ReFlow portfolio reinforces our commitment to advancing neurocritical care and patient well-being.”

The external ventricular drain market has witnessed selective merger and acquisition activity, with established medical device companies acquiring specialized neurocritical care firms to expand their product portfolios. These transactions are typically focused on gaining access to advanced catheter technologies, infection-control innovations, and integrated monitoring solutions. Although M&A activity is moderate compared to larger medical device segments, it plays a strategic role in strengthening market presence and enhancing technological capabilities. Overall, consolidation efforts aim to improve competitive positioning and expand global reach.

Regulatory requirements play a significant role in shaping the external ventricular drain industry, as these devices are classified as high-risk medical devices and require stringent approval processes, including FDA clearance and CE marking. Compliance with rigorous safety, performance, and clinical validation standards can prolong product development timelines and increase costs for manufacturers. However, regulatory oversight also enhances clinician confidence and patient safety, supporting broader adoption of advanced EVD systems. Overall, regulatory frameworks both challenge market entry and ensure high quality and reliability in the EVD space.

The market is highly concentrated in tertiary hospitals, specialized neurosurgical centers, and advanced ICUs, where comprehensive neurocritical care services are available. Major metropolitan hospitals account for a significant share of demand due to the need for skilled neurosurgical teams and continuous intracranial pressure monitoring. Trauma and stroke centers also contribute notably to device utilization. Adoption remains limited in smaller facilities due to infrastructure constraints and procedural complexity.

Application Insights

Traumatic brain injury dominated the external ventricular drain market in 2025, driven by the rising incidence of road traffic accidents, falls, and sports-related head injuries worldwide. The urgent requirement for intracranial pressure monitoring and cerebrospinal fluid drainage in severe TBI cases significantly increased the adoption of EVD systems across trauma centers and neuro-ICUs.

Intracerebral hemorrhage (ICH) is expected to witness the fastest growth during the forecast period, driven by the rising global incidence of hypertension and stroke-related complications. The increasing need for rapid intracranial pressure control and cerebrospinal fluid diversion in acute hemorrhagic cases is increasing EVD utilization. In addition, advancements in neuroimaging and early diagnosis are supporting timely intervention, further accelerating segment growth.

Patient Type Insights

The adult segment dominated the external ventricular drain industry in 2025, primarily due to the high prevalence of traumatic brain injuries, stroke, intracerebral hemorrhage, and hydrocephalus among the adult population. The growing burden of lifestyle-related risk factors, such as hypertension, further contributed to increased neurosurgical interventions. Higher hospitalization rates and access to advanced neurocritical care facilities also supported the segment’s leading market share.

The pediatric segment is expected to grow the fastest during the forecast period. The rising incidence of congenital hydrocephalus and neonatal brain injuries drives this growth. Improved early diagnosis and advancements in pediatric neurosurgical care support higher intervention rates. In addition, growing investments in specialized pediatric ICUs and enhanced awareness of early intracranial pressure management are further accelerating segment growth.

End Use Insights

The hospitals segment dominated the external ventricular drain market in 2025, as most EVD procedures are performed in tertiary care hospitals equipped with advanced neurosurgical and intensive care facilities. The availability of skilled neurosurgeons, continuous intracranial pressure monitoring systems, and emergency trauma services supports high procedure volumes in hospital settings. Furthermore, expanding ICU infrastructure, increasing trauma admissions, and rising investments in neurocritical care services are expected.

The hospitals segment is projected to register the fastest growth during the forecast period. This growth is supported by the continuous expansion of ICU infrastructure, a rising volume of trauma and stroke admissions, and increasing investments in advanced neurocritical care services across both public and private healthcare institutions.

Recent Developments

• In January 2025, Integra LifeSciences Holding Corporation, a global provider of medical technology, announced the launch of the Integra Institute, its new global medical education platform. This digital initiative is designed to strengthen the company’s medical education programs across surgical, neurologic, ENT, and regenerative care specialties by providing healthcare professionals with comprehensive, on-demand learning resources to support ongoing professional development.
• In May 2024, Medtronic Neurosurgery announced a recall of the Duet External Drainage and Monitoring System due to a risk that the catheter tubing could disconnect from the patient line stopcock connectors. The recall was issued to address this potential safety concern and prevent possible complications associated with unintended disconnection.
• In September 2025, B. Braun announced a manufacturing expansion in the Lehigh Valley, highlighting the region’s strong business environment as a key factor enabling the company to compete and succeed globally. The expansion is part of B. Braun’s broader commitment to enhancing production capabilities and supporting long-term growth in advanced medical technologies.

Global External Ventricular Drain Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global external ventricular drain market report based on product, patient type, end use, and region:

• Application Outlook (Revenue, USD Million, 2021 – 2033)
  • Traumatic Brain Injury
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage
  • Other Non-traumatic Hydrocephalus Conditions
• Patient Type Outlook (Revenue, USD Million, 2021 – 2033)
  • Adult
  • Pediatric
• End Use Outlook (Revenue, USD Million; 2021 – 2033)
  • Hospitals
  • Others
• Regional Outlook (Revenue, USD Million, 2021 – 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Sweden
    • Denmark
    • Norway
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Application
1.1.2. Patient Type
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Methodology & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. External Ventricular Drain Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising prevalence of neurological disorders
3.2.1.2. Growing incidence of road accidents & head trauma
3.2.1.3. Increase in neurosurgical & ICU procedures
3.2.2. Market Restraints Analysis
3.2.2.1. High risk of infections (EVD-associated infections)
3.2.2.2. High procedure & hospitalization costs
3.2.3. Market Opportunity Analysis
3.2.3.1. Development of infection-resistant EVD systems
3.2.3.2. Integration with advanced ICP monitoring technologies
3.2.3.3. Expansion in emerging markets
3.2.3.4. Technological advancements
3.2.4. Market Challenge Analysis
3.2.4.1. Catheter blockage & device malfunction
3.2.4.2. Stringent regulatory & compliance requirements
3.2.4.3. Competition from alternative CSF management solutions
3.3. External Ventricular Drain Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. External Ventricular Drain Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global External Ventricular Drain Market: Application Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global External Ventricular Drain Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
4.3.1. Traumatic Brain Injury
4.3.1.1. Traumatic brain injury market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.3.2. Subarachnoid Hemorrhage
4.3.2.1. Subarachnoid hemorrhage market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.3.3. Intracerebral Hemorrhage
4.3.3.1. Intracerebral hemorrhage market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.3.4. Other Non-traumatic Hydrocephalus Conditions
4.3.4.1. Other non-traumatic hydrocephalus conditions market revenue estimates and forecasts, 2021 – 2033 (USD Million)
Chapter 5. External Ventricular Drain Market: Patient Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global External Ventricular Drain Market: Patient Type Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2021 to 2033 (USD Million)
5.3.1. Adult
5.3.1.1. Adult market revenue estimates and forecasts, 2021 – 2033 (USD Million)
5.3.2. Pediatric
5.3.2.1. Pediatric market revenue estimates and forecasts, 2021 – 2033 (USD Million)
Chapter 6. External Ventricular Drain Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global External Ventricular Drain Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
6.3. Global External Ventricular Drain Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
6.3.1. Hospitals
6.3.1.1. Hospitals market revenue estimates and forecasts, 2021 – 2033 (USD Million)
6.3.2. Others
6.3.2.1. Others market revenue estimates and forecasts, 2021 – 2033 (USD Million)
Chapter 7. External Ventricular Drain Market: Regional Estimates & Trend Analysis by Application, Patient Type, and End Use
7.1. Regional Dashboard
7.2. Market Size and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Competitive scenario
7.3.2.3. Regulatory framework
7.3.2.4. Reimbursement scenario
7.3.2.5. U.S. external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Competitive scenario
7.3.3.3. Regulatory framework
7.3.3.4. Reimbursement scenario
7.3.3.5. Canada external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Competitive scenario
7.3.4.3. Regulatory framework
7.3.4.4. Reimbursement scenario
7.3.4.5. Mexico external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4. Europe
7.4.1. Europe external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Reimbursement scenario
7.4.2.5. UK external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Reimbursement scenario
7.4.3.5. Germany external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory framework
7.4.4.4. Reimbursement scenario
7.4.4.5. France external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Competitive scenario
7.4.5.3. Regulatory framework
7.4.5.4. Reimbursement scenario
7.4.5.5. Italy external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Competitive scenario
7.4.6.3. Regulatory framework
7.4.6.4. Reimbursement scenario
7.4.6.5. Spain external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Competitive scenario
7.4.7.3. Regulatory framework
7.4.7.4. Reimbursement scenario
7.4.7.5. Sweden external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Competitive scenario
7.4.8.3. Regulatory framework
7.4.8.4. Reimbursement scenario
7.4.8.5. Denmark external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key country dynamics
7.4.9.2. Competitive scenario
7.4.9.3. Regulatory framework
7.4.9.4. Reimbursement scenario
7.4.9.5. Norway external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement scenario
7.5.2.5. China external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.5.3. Japan
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Japan external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Reimbursement scenario
7.5.4.5. India external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Reimbursement scenario
7.5.5.5. South Korea external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.5.6. Australia
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Reimbursement scenario
7.5.6.5. Australia external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Reimbursement scenario
7.5.7.5. Thailand external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.6. Latin America
7.6.1. Latin America external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Brazil external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Argentina external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.7. Middle East and Africa
7.7.1. Middle East and Africa external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. South Africa external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Saudi Arabia external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. UAE external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Kuwait external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis, 2025
8.4. Company Heat Map Analysis
8.5. Strategy Mapping
8.5.1. Expansion
8.5.2. Mergers & Acquisition
8.5.3. Partnerships & Collaborations
8.5.4. New Product Launches
8.5.5. Research And Development
8.5.6. Company Profiles
8.5.7. Spiegelberg GmbH & Co. KG (Luciole Medical AG)
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Medtronic
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Sophysa
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Natus Medical Incorporated
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Neuromedex GmbH
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic initiatives
8.5.12. Integra LifeSciences
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Möller Medical GmbH ( Centrotec Sustainable AG)
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic initiatives
8.5.14. B. Braun SE
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product Benchmarking
8.5.14.4. Strategic initiatives
8.5.15. Fuji Systems
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product Benchmarking
8.5.15.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America external ventricular drain market, by region, 2021 – 2033 (USD Million)
Table 3 North America external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 4 North America external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 5 North America external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 6 U.S. external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 7 U.S. external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 8 U.S. external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 9 Canada external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 10 Canada external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 11 Canada external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 12 Mexico external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 13 Mexico external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 14 Mexico external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 15 Europe external ventricular drain market, by region, 2021 – 2033 (USD Million)
Table 16 Europe external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 17 Europe external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 18 Europe external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 19 Germany external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 20 Germany external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 21 Germany external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 22 UK external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 23 UK external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 24 UK external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 25 France external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 26 France external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 27 France external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 28 Italy external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 29 Italy external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 30 Italy external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 31 Spain external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 32 Spain external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 33 Spain external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 34 Denmark external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 35 Denmark external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 36 Denmark external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 37 Sweden external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 38 Sweden external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 39 Sweden external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 40 Norway external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 41 Norway external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 42 Norway external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 43 Asia Pacific external ventricular drain market, by region, 2021 – 2033 (USD Million)
Table 44 Asia Pacific external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 45 Asia Pacific external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 46 Asia Pacific external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 47 China external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 48 China external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 49 China external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 50 Japan external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 51 Japan external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 52 Japan external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 53 India external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 54 India external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 55 India external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 56 South Korea external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 57 South Korea external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 58 South Korea external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 59 Australia external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 60 Australia external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 61 Australia external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 62 Thailand external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 63 Thailand external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 64 Thailand external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 65 Latin America external ventricular drain market, by region, 2021 – 2033 (USD Million)
Table 66 Latin America external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 67 Latin America external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 68 Latin America external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 69 Brazil external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 70 Brazil external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 71 Brazil external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 72 Argentina external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 73 Argentina external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 74 Argentina external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 75 MEA external ventricular drain market, by region, 2021 – 2033 (USD Million)
Table 76 MEA external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 77 MEA external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 78 MEA external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 79 South Africa external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 80 South Africa external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 81 South Africa external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 82 Saudi Arabia external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 83 Saudi Arabia external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 84 Saudi Arabia external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 85 UAE external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 86 UAE external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 87 UAE external ventricular drain market, by end use, 2021 – 2033 (USD Million)
Table 88 Kuwait external ventricular drain market, by application, 2021 – 2033 (USD Million)
Table 89 Kuwait external ventricular drain market, by patient type, 2021 – 2033 (USD Million)
Table 90 Kuwait external ventricular drain market, by end use, 2021 – 2033 (USD Million)

List of Figures

Fig. 1 External ventricular drain market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data analysis models
Fig. 5 Market formulation and validation
Fig. 6 Data validating & publishing
Fig. 7 Market snapshot
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 External ventricular drain – market size and growth prospects (USD Million)
Fig. 11 External ventricular drain market: Industry Value Chain Analysis
Fig. 12 External ventricular drain market: Market Dynamics
Fig. 13 External ventricular drain market: PORTER’s Analysis
Fig. 14 External ventricular drain market: PESTEL Analysis
Fig. 15 External ventricular drain market share by application, 2025 & 2033 (USD Million)
Fig. 16 External ventricular drain market, by application: market share, 2025 & 2033
Fig. 17 Traumatic brain injury market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 18 Subarachnoid hemorrhage market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 19 Intracerebral hemorrhage market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 20 Other non-traumatic hydrocephalus conditions market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 21 External ventricular drain market share by patient type, 2025 & 2033 (USD Million)
Fig. 22 External ventricular drain market, by patient type: market share, 2025 & 2033
Fig. 23 Adult market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 24 Pediatric market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 25 External ventricular drain market share by end use, 2025 & 2033 (USD Million)
Fig. 26 External ventricular drain market, by end use: market share, 2025 & 2033
Fig. 27 Hospitals market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 28 Others market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 29 Regional marketplace: key takeaways
Fig. 30 North America external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 31 US external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 32 Canada external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 33 Mexico external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 34 Europe external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 35 UK external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 36 Germany external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 37 France external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 38 Italy external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 39 Spain external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 40 Sweden external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 41 Denmark external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 42 Norway external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 43 Asia Pacific external ventricular drain market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 44 China external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 45 Japan external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 46 India external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 47 South Korea external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 48 Australia external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 49 Thailand external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 50 Latin America external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 51 Brazil external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 52 Argentina external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 53 MEA external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 54 South Africa external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 55 Saudi Arabia external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 56 UAE external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 57 Kuwait external ventricular drain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 58 Key company categorization
Fig. 59 Company market positioning
Fig. 60 Key company market share analysis, 2025
Fig. 61 Strategic framework

---

---